サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1422745

経皮的冠動脈インターベンションの世界市場、予測（～2032年）

Percutaneous Coronary Intervention Market Research Report Forecast till 2032
出版日: | 発行: Market Research Future | ページ情報: 英文 180 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
経皮的冠動脈インターベンションの世界市場、予測（～2032年）
出版日: 2024年01月07日
発行: Market Research Future
ページ情報: 英文 180 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経皮的冠動脈インターベンションの市場規模は予測期間中に8.86%のCAGRを記録すると予測されています。

経皮的冠動脈インターベンションの市場は、機械的進歩、心血管感染症の拡大、高齢者人口の増加を原動力として力強い成長が見込まれています。

地域別では、北米地域が2022年に最大のシェアを示しました。このシェアは、低侵襲処置に対する需要の増加、心血管疾患の有病率の増加、不健康な生活習慣などの要因による市場成長に起因しています。一方、予測期間中はアジア太平洋地域が最大の成長を示す見通しです。所得水準の上昇、心血管疾患の有病率の増加、医療インフラの改善などの要因が同市場の成長を推進する見通しです。

当レポートでは、世界の経皮的冠動脈インターベンションの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 調査手法

第4章 市場力学

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場影響因子の分析

  • バリューチェーン分析
  • ポーターのファイブフォース分析 COVID-19の市場への影響 洞察: 経皮的冠動脈インターベンション製品の技術進歩

第6章 世界の経皮的冠動脈インターベンション市場：製品タイプ別

  • 冠状動脈ステント
  • バルーンカテーテル
  • 冠動脈ガイドワイヤー
  • ガイディングカテーテル
  • ガイディングシース
  • 診断用カテーテル
  • 交差カテーテル
  • 膨張デバイス
  • ガイダンスシステム
  • 末梢血栓除去システム
  • 塞栓防御システム
  • 付属品

第7章 世界の経皮的冠動脈インターベンション市場：血管アクセス別

  • 概要
    • 橈骨動脈
    • 大腿動脈

第8章 世界の経皮的冠動脈インターベンション市場：エンドユーザー別

  • 概要
    • 病院・診療所
    • 外来手術センター
    • その他

第9章 世界の経皮的冠動脈インターベンション市場：地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 概要
  • 競合ベンチマーキング
  • 主要企業の市場シェア分析
  • 主要な成長戦略
  • 開発件数のトップ企業
  • 主要な開発分析
  • 主な発展と成長戦略
  • 主要企業の財務状況

第11章 企業プロファイル

  • BOSTON SCIENTIFIC CORPORATION
  • ABBOTT
  • MEDTRONIC
  • COOK
  • MERIT MEDICAL SYSTEM
  • TERUMO CORPORATION
  • APT MEDICAL INC
  • BECTON, DICKINSON, AND COMPANY
  • B. BRAUN SE
  • CARDINAL HEALTH
  • MERIL LIFE SCIENCES PVT. LTD
  • PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD
  • MICROPORT SCIENTIFIC CORPORATION
  • LEPU MEDICAL TECHNOLOGY CO., LTD

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 3 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY STENTS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 4 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 5 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CORONARY GUIDEWIRES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDING SHEATHS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR DIAGNOSTICS CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR CROSSING CATHETERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR INFLATION DEVICE, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR GUIDANCE SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR PERIPHERAL THROMBECTOMY SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR EMBOLIC PROTECTION SYSTEM, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR ACCESSORIES, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR RADIAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR FEMORAL, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 19 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 20 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 21 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 22 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR OTHERS, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 23 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 24 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 25 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 26 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 27 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 28 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 29 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 30 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 31 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 32 US: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 33 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 34 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 35 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 36 CANADA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 37 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 38 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 39 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 40 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 41 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 42 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 43 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 44 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 45 GERMANY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 46 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 47 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 48 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 49 FRANCE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 50 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 51 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 52 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 53 UK: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 54 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 55 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 56 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 57 ITALY: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 58 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 59 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 60 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 61 SPAIN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 62 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 63 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 64 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 65 SWITZERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 66 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 67 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 68 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 69 NETHERLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 70 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 71 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 72 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 73 BELGIUM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 74 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 75 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 76 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 77 POLAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 78 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 79 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 80 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 81 REST OF EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2019-2032 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 87 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 88 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 89 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 90 CHINA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 91 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 92 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 93 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 94 JAPAN: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 95 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 96 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 97 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 98 INDIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 99 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 100 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 101 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 102 AUSTRALIA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 103 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 104 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 105 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 106 SOUTH KOREA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 107 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 108 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 109 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 110 SINGAPORE: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 111 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 112 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 113 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 114 THAILAND: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 115 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 116 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 117 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 118 VIETNAM: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 119 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 120 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 121 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 122 REST OF ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 123 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2019-2032 (USD MILLION)
  • TABLE 124 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 125 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 126 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 127 REST OF WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 128 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 129 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 130 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 131 AFRICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 132 LATIN AMERICA : PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 133 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 134 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 135 LATIN AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 136 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2019-2032 (USD MILLION)
  • TABLE 137 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET, FOR BALLON CATHETERS, BY TYPE, 2019-2032 (USD MILLION)
  • TABLE 138 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY VASCULAR ACCESS, 2019-2032 (USD MILLION)
  • TABLE 139 MIDDLE EAST: PERCUTANEOUS CORONARY INTERVENTION MARKET BY END USER, 2019-2032 (USD MILLION)
  • TABLE 140 MAJOR PLAYERS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • TABLE 141 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 142 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 143 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 144 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 145 AVERAGE PRICING (USD) AND VOLUME (TOTAL NO OF UNITS), 2022
  • TABLE 146 MOST ACTIVE PLAYER IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • TABLE 147 PRODUCT LAUNCH / PRODUCT APPROVAL
  • TABLE 148 AGREEMENT
  • TABLE 149 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 150 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 151 ABBOTT: PRODUCTS OFFERED
  • TABLE 152 ABBOTT: KEY DEVELOPMENTS
  • TABLE 153 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 154 MEDTRONIC: KEY DEVELOPMENTS
  • TABLE 155 COOK: PRODUCTS OFFERED
  • TABLE 156 MERIT MEDICAL SYSTEM: PRODUCTS OFFERED
  • TABLE 157 TERUMO CORPORATION: PRODUCTS OFFERED
  • TABLE 158 TERUMO CORPORATION: KEY DEVELOPMENTS
  • TABLE 159 APT MEDICAL INC: PRODUCTS OFFERED
  • TABLE 160 BECTON, DICKINSON, AND COMPANY: PRODUCTS OFFERED
  • TABLE 161 B. BRAUN SE: PRODUCTS OFFERED
  • TABLE 162 CARDINAL HEALTH: PRODUCTS OFFERED
  • TABLE 163 MERIL LIFE SCIENCES PVT. LTD: PRODUCTS OFFERED
  • TABLE 164 PLS MINIMALLY INVASIVE INTERNATIONAL MEDICAL CO LTD: PRODUCTS OFFERED
  • TABLE 165 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 166 MICROPORT SCIENTIFIC CORPORATION: KEY DEVELOPMENTS
  • TABLE 167 LEPU MEDICAL TECHNOLOGY CO., LTD: PRODUCTS OFFERE

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET STRUCTURE
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • FIGURE 9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 10 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD MILLION)
  • FIGURE 11 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE, BY PRODUCT TYPE, 2022
  • FIGURE 12 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, VASCULAR ACCESS SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 13 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS, 2022 & 2032 (USD MILLION)
  • FIGURE 14 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE, BY VASCULAR ACCESS, 2022 (USD MILLION)
  • FIGURE 15 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, END USER SEGMENT ATTRACTIVENESS, (USD MILLION)
  • FIGURE 16 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2022 & 2032 (USD MILLION)
  • FIGURE 17 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER, 2022 (USD MILLION)
  • FIGURE 18 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2022 & 2032 (USD MILLION)
  • FIGURE 19 GLOBAL: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY REGION, 2022
  • FIGURE 20 NORTH AMERICA MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2032 (USD MILLION)
  • FIGURE 21 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY,
  • FIGURE 22 NORTH AMERICA: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 23 EUROPE MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2032 (USD MILLION)
  • FIGURE 24 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2022 & 2032 (USD MILLION)
  • FIGURE 25 EUROPE: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 26 ASIA-PACIFIC MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2030 (USD MILLION)
  • FIGURE 27 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
  • FIGURE 28 ASIA-PACIFIC: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY COUNTRY, 2022
  • FIGURE 29 REST OF THE WORLD MARKET ANALYSIS: PERCUTANEOUS CORONARY INTERVENTION MARKET, 2019-2030 (USD MILLION)
  • FIGURE 30 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION, 2022 & 2030 (USD MILLION)
  • FIGURE 31 REST OT THE WORLD: PERCUTANEOUS CORONARY INTERVENTION MARKET SHARE (%), BY REGION, 2022
  • FIGURE 32 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 33 MAJOR MANUFACTURER MARKET SHARE ANALYSIS, 2022
  • FIGURE 34 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKEPT
  • FIGURE 35 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 36 MAJOR PLAYERS SALES (USD MILLION), 2022
  • FIGURE 37 MAJOR PLAYER R&D EXPENDITURE (USD MILLION), 2022
  • FIGURE 38 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 BOSTON SCIENTIFIC CORPORATION: SWOT ANALYSIS
  • FIGURE 40 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 ABBOTT: SWOT ANALYSIS
  • FIGURE 42 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 MEDTRONIC: SWOT ANALYSIS
  • FIGURE 44 MERIT MEDICAL SYSTEM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 46 APT MEDICAL INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 47 BECTON, DICKINSON, AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 48 BECTON, DICKINSON, AND COMPANY: SWOT ANALYSIS
  • FIGURE 49 B. BRAUN SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 50 B. BRAUN SE: SWOT ANALYSIS
  • FIGURE 51 CARDINAL HEALTH.: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 52 CARDINAL HEALTH: SWOT ANALYSIS
  • FIGURE 53 MICROPORT SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 54 LEPU MEDICAL TECHNOLOGY CO., LTD: FINANCIAL OVERVIEW SNAPSHOT
目次
Product Code: MRFR/MED/2288-CR

Percutaneous Coronary Intervention Market Research Report Forecast till 2030

Overview

The Percutaneous Coronary Intervention Market is anticipated to register a notable CAGR of 8.86% during the forecast period.

The percutaneous coronary intervention market is set for vigorous growth driven by mechanical progressions, expanding commonness of cardiovascular infections, and a rising maturing populace. With an emphasis on insignificantly obtrusive techniques and creative stent innovations, the market is ready to observe supported extension, offering worked on quiet results, and adding to the development of interventional cardiology.

The normal growth in the market can be ascribed to the rising predominance of heart sicknesses and expanding inclination for negligibly obtrusive methodology.

Throughout recent years, the quantity of death and handicaps brought about via cardiovascular infection has ceaselessly expanded all over the planet. The issue, which incorporates coronary illness and stroke, was answerable for 33% of the passings across the globe in 2019. For example, in 2019, the World Wellbeing Organization assessed that almost 17.9 million people passed on from cardiovascular illnesses, representing 32% of every worldwide casualty. Respiratory failures and strokes were liable for 85% of these fatalities. Unfortunate food, actual latency, cigarette use, and hazardous liquor utilization are the most major conduct risk factors for coronary illness and stroke.

Market Segmentation

The Percutaneous Coronary Intervention Market segmentation, based on product type, includes coronary stents, ballon catheters, coronary guidewires, guiding catheters, guiding sheaths, diagnostic catheters, crossing catheters, inflation device, guidance system, peripheral thrombectomy system, embolic protection system, and accessories.

The Percutaneous Coronary Intervention Market segmentation, based on vascular access, includes radial and femoral.

The Percutaneous Coronary Intervention Market segmentation, based on end user, includes hospitals & clinics, ambulatory surgical centers, and others.

Regional Insights

The North America percutaneous coronary intervention market accounted for the largest market share in 2022. North America is further divided into the US and Canada. North America held the largest market share due to the increase in demand for minimally invasive procedures, increasing prevalence of cardiovascular diseases, and unhealthy lifestyle habits propelling regional market growth over the forecast period.

Europe percutaneous coronary intervention market accounted for the second-largest market share due to unhealthy lifestyle habits, increasing geriatric population, and extensive R&D activities. Furthermore, the Germany percutaneous coronary intervention market is attributed to hold the largest market share.

The Asia-Pacific percutaneous coronary intervention market is expected to be the fastest growing from 2023 to 2032 due to rising income levels, an increase in the prevalence of cardiovascular diseases, and better healthcare infrastructure. Moreover, China percutaneous coronary intervention market accounted to hold the largest market share, and the India percutaneous coronary intervention market is projected to be the fastest growing market in the Asia-Pacific region.

Major Players

Key Companies in the Percutaneous Coronary Intervention market includes Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Medtronic (Ireland), Cook (US), APT Medical Inc (China), Merit Medical System (US), Becton, Dickinson, and Company (US), Braun SE (Germany), Cardinal Health (US), Meril Life Sciences Pvt. Ltd (India), PLS Minimally Invasive International Medical Co Ltd (China), and Lepu Medical Technology Co., Ltd (China).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

  • 1.1 OVERVIEW

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
    • 3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.4 FORECASTING TECHNIQUES
  • 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.5.1 BOTTOM-UP APPROACH
    • 3.5.2 TOP-DOWN APPROACH
  • 3.6 DATA TRIANGULATION
  • 3.7 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 RISING PREVALENCE OF HEART DISEASES
    • 4.2.2 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
  • 4.3 RESTRAINTS
    • 4.3.1 RISK OF INFECTION
    • 4.3.2 COMPLICATIONS DURING CARDIAC CATHETERIZATION
  • 4.4 OPPORTUNITIES
    • 4.4.1 GROWING TECHNOLOGICAL ADVANCEMENTS

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON KEY PLAYERS
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY
  • 5.4 INSIGHTS: TECHNOLOGICAL ADVANCEMENT FOR PERCUTANEOUS CORONARY INTERVENTION PRODUCTS

6 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
    • 6.1.1 CORONARY STENTS
    • 6.1.2 BALLON CATHETERS
    • 6.1.3 CORONARY GUIDEWIRES
    • 6.1.4 GUIDING CATHETERS
    • 6.1.5 GUIDING SHEATHS
    • 6.1.6 DIAGNOSTIC CATHETERS
    • 6.1.7 CROSSING CATHETERS
    • 6.1.8 INFLATION DEVICE
    • 6.1.9 GUIDANCE SYSTEM
    • 6.1.10 PERIPHERAL THROMBECTOMY SYSTEM
    • 6.1.11 EMBOLIC PROTECTION SYSTEM
    • 6.1.12 ACCESSORIES

7 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY VASCULAR ACCESS

  • 7.1 OVERVIEW
    • 7.1.1 RADIAL
    • 7.1.2 FEMORAL

8 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY END USER

  • 8.1 OVERVIEW
    • 8.1.1 HOSPITALS & CLINICS
    • 8.1.2 AMBULATORY SURGICAL CENTERS
    • 8.1.3 OTHERS

9 GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 FRANCE
    • 9.3.3 UK
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 SWITZERLAND
    • 9.3.7 NETHERLAND
    • 9.3.8 BELGIUM
    • 9.3.9 POLAND
    • 9.3.10 REST OF EUROPE
  • 9.4 ASIA-PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 AUSTRALIA
    • 9.4.5 SOUTH KOREA
    • 9.4.6 SINGAPORE
    • 9.4.7 THAILAND
    • 9.4.8 VIETNAM
    • 9.4.9 REST OF ASIA-PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 AFRICA
    • 9.5.2 LATIN AMERICA
    • 9.5.3 MIDDLE EAST

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MARKET SHARE ANALYSIS MAJOR PLAYER
    • 10.3.1 BOSTON SCIENTIFIC CORPORATION
    • 10.3.2 ABBOTT
    • 10.3.3 MEDTRONIC
    • 10.3.4 TERUMO CORPORATION
    • 10.3.5 MICROPORT SCIENTIFIC CORPORATION
  • 10.4 MAJOR GROWTH STRATEGY IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • 10.5 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL PERCUTANEOUS CORONARY INTERVENTION MARKET
  • 10.6 KEY DEVELOPMENT ANALYSIS
  • 10.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.7.1 PRODUCT LAUNCH / PRODUCT APPROVAL
    • 10.7.2 AGREEMENT
  • 10.8 MAJOR PLAYERS FINANCIAL
    • 10.8.1 SALES (USD MILLION), 2022
    • 10.8.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022

11 COMPANY PROFILES

  • 11.1 BOSTON SCIENTIFIC CORPORATION
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 ABBOTT
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 MEDTRONIC
    • 11.3.1 COMPANY OVERVIEWS
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 COOK
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 KEY STRATEGIES
  • 11.5 MERIT MEDICAL SYSTEM
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 KEY STRATEGIES
  • 11.6 TERUMO CORPORATION
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY DEVELOPMENTS
    • 11.6.6 KEY STRATEGIES
  • 11.7 APT MEDICAL INC
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 BECTON, DICKINSON, AND COMPANY
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 SWOT ANALYSIS
    • 11.8.6 KEY STRATEGIES
  • 11.9 B. BRAUN SE
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 SWOT ANALYSIS
    • 11.9.6 KEY STRATEGIES
  • 11.10 CARDINAL HEALTH
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES
  • 11.11 MERIL LIFE SCIENCES PVT. LTD
    • 11.11.1 COMPANY OVERVIEWS
    • 11.11.2 FINANCIAL OVERVIEW
    • 11.11.3 PRODUCTS OFFERED
    • 11.11.4 KEY DEVELOPMENTS
    • 11.11.5 KEY STRATEGIES
  • 11.12 PLS MINIMALLY INVASIVE INTERVENTIONAL MEDICAL CO., LTD
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 FINANCIAL OVERVIEW
    • 11.12.3 PRODUCTS OFFERED
    • 11.12.4 KEY DEVELOPMENTS
    • 11.12.5 KEY STRATEGIES
  • 11.13 MICROPORT SCIENTIFIC CORPORATION
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 FINANCIAL OVERVIEW
    • 11.13.3 PRODUCTS OFFERED
    • 11.13.4 KEY DEVELOPMENTS
    • 11.13.5 KEY STRATEGIES
  • 11.14 LEPU MEDICAL TECHNOLOGY CO., LTD
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 FINANCIAL OVERVIEW
    • 11.14.3 PRODUCTS OFFERED
    • 11.14.4 KEY DEVELOPMENTS
    • 11.14.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS